Novel immunotherapy in metastatic renal cell carcinoma. – UroToday
|
Novel immunotherapy in metastatic renal cell carcinoma.
UroToday Despite the rapid development of therapeutic modalities for metastatic renal cell carcinoma (mRCC) over the past decade to include a number of targeted antiangiogenic therapies and traditional immunotherapy, such as high-dose interleukin-2 and … |
